Search Results

Taladegib 5 mg  | 98.75%

TargetMol

Taladegib is an orally bioavailable small molecule antagonist of the Hedgehog (Hh)-ligand cell surface receptor smoothened (Smo) with potential antineoplastic activity.

More Information Supplier Page

(E)-Daporinad 50 mg  | Purity Not Available

TargetMol

Daporinad is a small molecule inhibitor of nicotinamide phosphoribosyltransferase (NMPRTase), with potential antineoplastic and antiangiogenic activities.

More Information Supplier Page

(E)-Daporinad 5 mg  | Purity Not Available

TargetMol

Daporinad is a small molecule inhibitor of nicotinamide phosphoribosyltransferase (NMPRTase), with potential antineoplastic and antiangiogenic activities.

More Information Supplier Page

GSK2656157 100 mg  | 99.89%

TargetMol

GSK2656157 is a highly specific and ATP-competitive PERK inhibitor (IC50: 0.9 nM) in a cell-free assay. The selectivty is 500-fold higher against a panel of 300 kinases.

More Information Supplier Page

GSK2656157 10 mg  | 99.89%

TargetMol

GSK2656157 is a highly specific and ATP-competitive PERK inhibitor (IC50: 0.9 nM) in a cell-free assay. The selectivty is 500-fold higher against a panel of 300 kinases.

More Information Supplier Page

CEP-37440 10 mg  | 99.01%

TargetMol

CEP-37440 is an effective and specific Dual FAK/ALK inhibitor with IC50s of 120 nM(ALK cellular in 75% human plasma) and 2.3 nM (FAK).

More Information Supplier Page

CEP-37440 2 mg  | 99.01%

TargetMol

CEP-37440 is an effective and specific Dual FAK/ALK inhibitor with IC50s of 120 nM(ALK cellular in 75% human plasma) and 2.3 nM (FAK).

More Information Supplier Page

CEP-37440 50 mg  | 99.01%

TargetMol

CEP-37440 is an effective and specific Dual FAK/ALK inhibitor with IC50s of 120 nM(ALK cellular in 75% human plasma) and 2.3 nM (FAK).

More Information Supplier Page

CEP-37440 5 mg  | 99.01%

TargetMol

CEP-37440 is an effective and specific Dual FAK/ALK inhibitor with IC50s of 120 nM(ALK cellular in 75% human plasma) and 2.3 nM (FAK).

More Information Supplier Page